Moma Therapeutics
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
Last updated on
About Moma Therapeutics
Founded
2020Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$236MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
28NAICs Code
32Location
City
CambridgeState
MassachusettsCountry
United StatesMoma Therapeutics
Find your buyer within Moma Therapeutics